BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33299429)

  • 1. Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: single-institution experience.
    Tagliaferri L; Carra N; Lancellotta V; Rizzo D; Casà C; Mattiucci G; Parrilla C; Fionda B; Deodato F; Cornacchione P; Gambacorta MA; Paludetti G; Valentini V; Bussu F
    J Contemp Brachytherapy; 2020 Oct; 12(5):413-419. PubMed ID: 33299429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncological follow-up after mold-based pulsed dose rate brachytherapy for early stage squamous cell carcinoma of the nasal vestibule: A single center experience of 68 patients over a 17-year period.
    Scheurleer WFJ; Dehnad H; Braunius WW; Janssen LM; Tijink BM; Breimer GE; Smid EJ; Devriese LA; Bree R; Ridder M; Rijken JA
    Brachytherapy; 2023; 22(2):221-230. PubMed ID: 36539317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial radiation therapy for early-stage nasal vestibule cancer: a continuing quest for optimal tumor control and cosmesis.
    Levendag PC; Nijdam WM; van Moolenburgh SE; Tan L; Noever I; van Rooy P; Mureau MA; Jansen PP; Munte K; Hofer SO
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):160-9. PubMed ID: 16839706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas.
    Bussu F; Tagliaferri L; De Corso E; Passali GC; Lancellotta V; Mattiucci GC; Gambacorta MA; Rizzo D; Di Cintio G; Salvati A; Paludetti G; Valentini V; Galli J
    Brachytherapy; 2021; 20(1):178-184. PubMed ID: 33041229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary approach to nose vestibule malignancies: setting new standards.
    Bussu F; Tagliaferri L; Piras A; Rizzo D; Tsatsaris N; De Corso E; Parrilla C; Paludetti G
    Acta Otorhinolaryngol Ital; 2021 Apr; 41(Suppl. 1):S158-S165. PubMed ID: 34060531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiation of localized squamous cell carcinoma of the nasal vestibule.
    Vanneste BG; Lopez-Yurda M; Tan IB; Balm AJ; Borst GR; Rasch CR
    Head Neck; 2016 Apr; 38 Suppl 1():E1870-5. PubMed ID: 26706779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional radiotherapy (brachytherapy) for squamous cell carcinoma of the nasal vestibule: a multidisciplinary systematic review.
    Tagliaferri L; Fionda B; Bussu F; Parrilla C; Lancellotta V; Deodato F; Cammelli S; Boldrini L; Gambacorta MA; Morganti AG; Valentini V; Paludetti G; Peris K; Kovacs G
    Eur J Dermatol; 2019 Aug; 29(4):417-421. PubMed ID: 31486400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face Cancer.
    Tagliaferri L; Giarrizzo I; Fionda B; Rigante M; Pagliara MM; Casà C; Parrilla C; Lancellotta V; Placidi E; Salvati A; Macchia G; Gentileschi S; Blasi MA; Morganti AG; Bussu F; Peris K; Paludetti G; Valentini V
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy as nose preservation treatment strategy for cancer of the nasal vestibule: The Dutch experience.
    Czerwinski MD; Jansen PP; Zwijnenburg EM; Al-Mamgani A; Vergeer MR; Langendijk JA; Wesseling FWR; Kaanders JHAM; Verhoef CG
    Radiother Oncol; 2021 Nov; 164():20-26. PubMed ID: 34487765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image Guided Brachytherapy for Cancer of the Nasal Vestibule: Local Control and Cosmesis.
    Czerwinski MD; van Leeuwen RGH; Kaanders JHAM; Zwijnenburg EM; Lipman D; Takes RP; Verhoef CG
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):913-921. PubMed ID: 30458233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
    Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
    Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
    Cordoba A; Escande A; Lopez S; Mortier L; Mirabel X; Coche-Déqueant B; Lartigau E
    Radiat Oncol; 2016 Jul; 11():96. PubMed ID: 27464910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
    Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
    Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy.
    Tsang YM; Tharmalingam H; Belessiotis-Richards K; Armstrong S; Ostler P; Hughes R; Alonzi R; Hoskin PJ
    Radiother Oncol; 2021 May; 158():184-190. PubMed ID: 33639192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of radiation therapy for unresected soft-tissue sarcomas.
    Kepka L; DeLaney TF; Suit HD; Goldberg SI
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):852-9. PubMed ID: 16199316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.